Chemical Structure : KX2-391
CAS No.: 897016-82-9
Catalog No.: PC-42537Not For Human Use, Lab Use Only.
KX2-391(Tirbanibulin, KX 01, KX 2-391) is a highly selective, non-ATP competitive substrate-pocket-directed Src/pretubulin inhibitor.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $78 | In stock | |
25 mg | $128 | In stock | |
50 mg | $218 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
KX2-391 (Tirbanibulin, KX 01, KX 2-391) is a highly selective, non-ATP competitive substrate-pocket-directed Src/pretubulin inhibitor.
KX2-391 (Tirbanibulin, KX 01, KX 2-391) inhibits c-Src kinase with GI50s of 1.34 uM and 2.30 μM in NIH3T3/c-Src527F and SYF/c-Src527F cells, respectively.
KX2-391 (Tirbanibulin, KX 01, KX 2-391) causes microtubule disruption in tumor cells.
KX2-391 (Tirbanibulin, KX 01, KX 2-391) is orally active.
M.Wt | 431.5268 | |
Formula | C26H29N3O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2-Pyridineacetamide, 5-[4-[2-(4-morpholinyl)ethoxy]phenyl]-N-(phenylmethyl)- |
1. Fallah-Tafti A, et al. Eur J Med Chem. 2011 Oct;46(10):4853-8.
2. Anbalagan M, et al. Mol Cancer Ther. 2012 Sep;11(9):1936-47.
3. Liu T, et al. Clin Cancer Res. 2013 Dec 1;19(23):6532-43.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright